Lanisidenib

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C28H23ClF3N5O4S
Molecular Weight	618.027
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

FC1=CC(=CC=C1)N([C@H](C(=O)NC2CC(F)(F)C2)C3=CC=CC=C3Cl)C(=O)[C@@H]4CCS(=O)(=O)N4C5=NC=CC(=C5)C#N

InChI

InChIKey=LJHJHBULGHFPID-ZCYQVOJMSA-N

InChI=1S/C28H23ClF3N5O4S/c29-22-7-2-1-6-21(22)25(26(38)35-19-14-28(31,32)15-19)36(20-5-3-4-18(30)13-20)27(39)23-9-11-42(40,41)37(23)24-12-17(16-33)8-10-34-24/h1-8,10,12-13,19,23,25H,9,11,14-15H2,(H,35,38)/t23-,25-/m0/s1

HIDE SMILES / InChI

Approval Year

Name

Type

Language

(3S)-N-{(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl}-2-(4-cyanopyridin-2-yl)-N-(3-fluorophenyl)-1,1-dioxo-1?<sup>6</sup>,2-thiazolidine-3-carboxamide

Preferred Name

English

Lanisidenib

Official Name

English

3-Isothiazolidinecarboxamide, N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-2-(4-cyano-2-pyridinyl)-N-(3-fluorophenyl)-, 1,1-dioxide, (3S)-

Systematic Name

English

lanisidenib [INN]

Common Name

English

Code System Code Type Description

INN

13368

Created by admin on Wed Apr 02 20:59:35 GMT 2025 , Edited by admin on Wed Apr 02 20:59:35 GMT 2025

PRIMARY

CAS

2135537-20-9

Created by admin on Wed Apr 02 20:59:35 GMT 2025 , Edited by admin on Wed Apr 02 20:59:35 GMT 2025

PRIMARY

FDA UNII

G5J396CG5J

Created by admin on Wed Apr 02 20:59:35 GMT 2025 , Edited by admin on Wed Apr 02 20:59:35 GMT 2025

PRIMARY

PUBCHEM

142547299

Created by admin on Wed Apr 02 20:59:35 GMT 2025 , Edited by admin on Wed Apr 02 20:59:35 GMT 2025

PRIMARY

ACTIVE MOIETY


					G5J396CG5J

Lanisidenib